Mixed connective tissue disease other diagnostic studies: Difference between revisions
Jump to navigation
Jump to search
| Line 8: | Line 8: | ||
=== Pulmonary function test === | === Pulmonary function test === | ||
*Pulmonary function test may be helpful in the diagnosis of | *[[Spirometry|Pulmonary function test]] may be helpful in the diagnosis of [[interstitial lung disease]] as a [[Complication (medicine)|complication]] of MCTD. Findings suggestive of [[interstitial lung disease]] include:<ref name="pmid15716315">{{cite journal |vauthors=Bodolay E, Szekanecz Z, Dévényi K, Galuska L, Csípo I, Vègh J, Garai I, Szegedi G |title=Evaluation of interstitial lung disease in mixed connective tissue disease (MCTD) |journal=Rheumatology (Oxford) |volume=44 |issue=5 |pages=656–61 |date=May 2005 |pmid=15716315 |doi=10.1093/rheumatology/keh575 |url=}}</ref><ref name="pmid23125954">{{cite journal |vauthors=Gutsche M, Rosen GD, Swigris JJ |title=Connective Tissue Disease-associated Interstitial Lung Disease: A review |journal=Curr Respir Care Rep |volume=1 |issue= |pages=224–232 |date=September 2012 |pmid=23125954 |pmc=3486427 |doi=10.1007/s13665-012-0028-7 |url=}}</ref> | ||
**DLCO values is significantly lower in the active pulmonary stage (most sensitive test for predicting the presence of fibrosing alveolitis) | **[[DLCO]] values is significantly lower in the active pulmonary stage (most [[Sensitivity (tests)|sensitive]] test for predicting the presence of fibrosing [[alveolitis]]) | ||
**Restrictive ventilatory defect (reduction of FEV1 and total lung capacity) | **[[Restrictive lung disease|Restrictive ventilatory defect]] (reduction of FEV1 and total lung capacity) | ||
==References== | ==References== | ||
Revision as of 15:58, 12 April 2018
|
Mixed connective tissue disease Microchapters |
|
Differentiating Mixed connective tissue disease from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Mixed connective tissue disease other diagnostic studies On the Web |
|
American Roentgen Ray Society Images of Mixed connective tissue disease other diagnostic studies |
|
FDA on Mixed connective tissue disease other diagnostic studies |
|
Mixed connective tissue disease other diagnostic studies in the news |
|
Blogs onMixed connective tissue disease other diagnostic studies |
|
Directions to Hospitals Treating Mixed connective tissue disease |
|
Risk calculators and risk factors for Mixed connective tissue disease other diagnostic studies |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Shaghayegh Habibi, M.D.[2]
Overview
Other Diagnostic Studies
Pulmonary function test
- Pulmonary function test may be helpful in the diagnosis of interstitial lung disease as a complication of MCTD. Findings suggestive of interstitial lung disease include:[1][2]
- DLCO values is significantly lower in the active pulmonary stage (most sensitive test for predicting the presence of fibrosing alveolitis)
- Restrictive ventilatory defect (reduction of FEV1 and total lung capacity)
References
- ↑ Bodolay E, Szekanecz Z, Dévényi K, Galuska L, Csípo I, Vègh J, Garai I, Szegedi G (May 2005). "Evaluation of interstitial lung disease in mixed connective tissue disease (MCTD)". Rheumatology (Oxford). 44 (5): 656–61. doi:10.1093/rheumatology/keh575. PMID 15716315.
- ↑ Gutsche M, Rosen GD, Swigris JJ (September 2012). "Connective Tissue Disease-associated Interstitial Lung Disease: A review". Curr Respir Care Rep. 1: 224–232. doi:10.1007/s13665-012-0028-7. PMC 3486427. PMID 23125954.